Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients [Phase 2]
Phase 2 trial update evaluating pharmacodynamic parameters and tolerability of grass pollen subcutaneous immunotherapy in patients with alle…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch [Phase 2]
Phase 2 study evaluating efficacy and tolerability of two administration routes for SLITonePLUS Birch in birch pollen–related allergic rhini…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine [Phase 3]
A Phase 3 trial assessing tolerability of Grazax taken with an antihistamine in allergic rhinitis has completed.
-
CLINICAL_TRIALS research · 2013-02-07Clinical Trial Update: Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites [Phase 4]
This report provides an update on a Phase 4 trial evaluating house dust mite sublingual immunotherapy in children with asthma or allergic rh…
-
FDA approval · 2013-02-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for montelukast sodium submitted by Dr. Reddy's Laboratories Limited. The approval extends the r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-02-05FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark Pharmaceuticals Inc., USA's supplemental application for levocetirizine dihydrochloride, a generic antihistamine u…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug [Phase 2]
This update reports the termination of a Phase 2 trial evaluating an immunostimulatory drug for ragweed-induced asthma.
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Repeated Nasal Challenge in Skin Prick-puncture Negative and Intradermal Positive Dust Mite Allergic Rhinitis Patients [NA]
This is a completed ClinicalTrials.gov entry for a study evaluating repeated nasal challenges in dust mite–sensitized allergic rhinitis pati…
-
FDA approval · 2013-01-30FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Camber Pharmaceuticals' generic levocetirizine dihydrochloride.
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: A Trial of the ALK Grass Tablet in Subjects With Hayfever [Phase 3]
A Phase 3 trial evaluating the ALK Grass Tablet for allergic rhinitis (hay fever) has completed.
-
FDA approval · 2013-01-28FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for Montelukast Sodium from Torrent Pharmaceuticals Limited. This action confirms continued mark…
-
FDA approval · 2013-01-28FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental ANDA for a generic montelukast sodium product submitted by Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children [Phase 1]
A Phase 1 pharmacokinetics study evaluating doxylamine succinate in children has been completed with results posted.
-
FDA approval · 2013-01-04FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add a grape and bubblegum flavor for Claritin chewable (loratadine) manufactured by Bayer HealthC…
-
FDA approval · 2013-01-02FDA Approved: FEXOFENADINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The U.S. FDA approved a supplemental application for fexofenadine hydrochloride from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2012-12-30FDA Approved: PROMETHEGAN — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Cosette Pharmaceuticals' PROMETHEGAN (promethazine hydrochloride), updating its labeling und…
-
FDA approval · 2012-12-13FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for montelukast sodium filed by Rising Pharma Holdings, Inc., indicating approval of a change or add…
-
FDA approval · 2012-12-10FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved the supplemental application for Montelukast Sodium from Dr. Reddy's Laboratories Limited, granting approval for this generic m…
-
FDA approval · 2012-12-10FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium from Dr.Reddy's Laboratories Limited (ANDA201581).
-
FDA approval · 2012-12-05FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochloride) …
-
FDA approval · 2012-12-05FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochloride) …
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition [Phase 1]
Phase 1 bioequivalence study of Levocetirizine Dihydrochloride 5 mg tablets completed under fasting conditions.
-
FDA approval · 2012-11-30FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Montelukast Sodium by Rising Pharma Holdings, Inc., enabling a generic version of Montelukast so…
-
FDA approval · 2012-11-29FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Dr.Reddy's laboratories Ltd.)
FDA approved a supplemental application for levocetirizine dihydrochloride from Dr. Reddy's Laboratories Ltd., granting approval to an exist…
-
FDA approval · 2012-11-29FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Levocetirizine Dihydrochloride from Camber Pharmaceuticals, Inc.